Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
暂无分享,去创建一个
D. Gevers | G. Kaplan | M. Silverberg | T. Karlsen | M. Vatn | A. Tyler | J. Hov | K. Holm | D. Kevans | B. Eksteen | K. Jørgensen
[1] E. Zoetendal,et al. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. , 2015, Journal of Crohn's & colitis.
[2] Rob Knight,et al. Advancing the Microbiome Research Community , 2014, Cell.
[3] M. Silverberg,et al. Analyzing the Human Microbiome: A “How To” guide for Physicians , 2014, The American Journal of Gastroenterology.
[4] C. Huttenhower,et al. Inflammatory bowel disease as a model for translating the microbiome. , 2014, Immunity.
[5] C. Huttenhower,et al. Relating the metatranscriptome and metagenome of the human gut , 2014, Proceedings of the National Academy of Sciences.
[6] Se Jin Song,et al. The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.
[7] J. Talwalkar,et al. Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis , 2013, BioMed research international.
[8] M. Icaza-Chávez,et al. Microbiota intestinal en la salud y la enfermedad , 2013 .
[9] Kai-Uwe Eckardt,et al. Evolving importance of kidney disease: from subspecialty to global health burden , 2013, The Lancet.
[10] Judy H. Cho,et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis , 2013, Nature Genetics.
[11] Falk Hildebrand,et al. Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice , 2013, Genome Biology.
[12] B. Finlay,et al. The gut microbiota: challenging immunology , 2011, Nature Reviews Immunology.
[13] G. Kaplan,et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. , 2011, Hepatology.
[14] K. Lindor,et al. Treatment options for primary sclerosing cholangitis , 2010, Expert review of gastroenterology & hepatology.
[15] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[16] C. Moreno,et al. A consistent terminology for quantifying species diversity? , 2010, Oecologia.
[17] G. Gores,et al. Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.
[18] G. Kaplan,et al. The Burden of Large and Small Duct Primary Sclerosing Cholangitis in Adults and Children: A Population-Based Analysis , 2007, The American Journal of Gastroenterology.
[19] R. Knight,et al. Quantitative and Qualitative β Diversity Measures Lead to Different Insights into Factors That Structure Microbial Communities , 2007, Applied and Environmental Microbiology.
[20] J. Satsangi,et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[21] C. Benz,et al. [Primary sclerosing cholangitis]. , 2000, Der Internist.
[22] R. Groszmann,et al. American association for the study of liver diseases , 1992 .
[23] R. Clark,et al. Biliary tract disease in rats with experimental small bowel bacterial overgrowth , 1991, Hepatology.
[24] Robert C. Edgar,et al. Search and clustering orders of magnitude faster than BLAST , 2010 .